Life Sciences Real Estate team

We spoke with George Fraser-Harding, head of European Funds at Aviva Investors, about life sciences real estate. Aviva Investors has

Mission Street is a specialist investor, developer and operator for the science and innovation sector. The company’s science and

Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating

We caught up with Karolina Karl who leads the life sciences team at Invest Lithuania, the country’s inward investment

If a company’s core business can generate profits of 15 per cent to 20 per cent, it makes sense to allocate capital into the core business and away from real estate, where returns are likely to be in the 6% to 8% range.